Workshops & speaking topics
Keynotes and working sessions for leadership teams, program teams, and industry audiences in rare disease and gene therapy.
Explore workshop topics ↓
Book a session ↓
Before Approval,
While It Is Still Cheap
Endpoints, comparators, trial design, evidence gaps, and what each choice will cost you three years from now. Every one of these is fixable years earlier than it is usually found.
Global by Design,
Not by Default
How organizations can build global access, reimbursement, evidence, and patient strategies early rather than treating markets outside the United States as a later consideration.
Evidence That Opens Doors and Keeps Them Open
How to create evidence, registries, real-world data, and signal systems that challenge assumptions and change decisions while there is still time to act.
Managing Risk, Timing, and the Closing Window
How leaders can prioritize gaps based on two factors: the potential impact on patient access, and how quickly the opportunity to correct the problem is closing.
